MANKIND PHARMA
Back to Balance Sheet
|
MANKIND PHARMA Last 5 Year Deferred Tax Assets / Liabilities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Deferred Tax Assets / Liabilities | ₹1,705 Cr | ₹8.68 Cr | ₹48 Cr | ₹16 Cr | ₹-36 Cr |
What is the latest Deferred Tax Assets / Liabilities ratio of MANKIND PHARMA ?
| Year | Deferred Tax Assets / Liabilities |
|---|---|
| Mar2025 | ₹1,705 Cr |
| Mar2024 | ₹8.68 Cr |
| Mar2023 | ₹48 Cr |
| Mar2022 | ₹16 Cr |
| Mar2021 | ₹-36 Cr |
How is Deferred Tax Assets / Liabilities of MANKIND PHARMA Trending?
| Years | Deferred Tax Assets / Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹1,705 Cr | 19,538.48 | |
| Mar2024 | ₹8.68 Cr | -81.74 | |
| Mar2023 | ₹48 Cr | 191.02 | |
| Mar2022 | ₹16 Cr | Positive | |
| Mar2021 | ₹-36 Cr | - | |
Compare Deferred Tax Assets / Liabilities of peers of MANKIND PHARMA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| MANKIND PHARMA | ₹92,956.4 Cr | 1.4% | -7.9% | -13% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹439,378.0 Cr | 2.8% | 6.7% | 2.8% | Stock Analytics | |
| DIVIS LABORATORIES | ₹171,996.0 Cr | 1.9% | -0.5% | 6.9% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹125,959.0 Cr | 0.1% | 3.4% | 15.8% | Stock Analytics | |
| CIPLA | ₹123,666.0 Cr | 1.8% | -3.2% | 2.1% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹105,008.0 Cr | 2.7% | 0.4% | 3.4% | Stock Analytics | |
MANKIND PHARMA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| MANKIND PHARMA | 1.4% |
-7.9% |
-13% |
| SENSEX | 0.6% |
1.3% |
7% |
You may also like the below Video Courses